{
  "id": "baf60d7e2c5dd4f1",
  "title": "Granule generic for ADHD secures U . S . FDA tentative nod",
  "description": "20251222T110000Z",
  "content": "",
  "source": "thehindu.com",
  "source_url": "https://www.thehindu.com/business/Industry/granules-generic-for-adhd-secures-us-fda-tentative-nod/article70425051.ece",
  "published_at": "20251222T110000Z",
  "fetched_at": "2025-12-23T00:22:44.609575+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "India",
  "raw_data": {
    "url": "https://www.thehindu.com/business/Industry/granules-generic-for-adhd-secures-us-fda-tentative-nod/article70425051.ece",
    "url_mobile": "https://www.thehindu.com/business/Industry/granules-generic-for-adhd-secures-us-fda-tentative-nod/article70425051.ece/amp/",
    "title": "Granule generic for ADHD secures U . S . FDA tentative nod",
    "seendate": "20251222T110000Z",
    "socialimage": "https://th-i.thgim.com/public/incoming/5jkjt0/article69254050.ece/alternates/LANDSCAPE_1200/2025-02-21T201832Z_529370379_RC27ZCA77WOM_RTRMADP_3_MIRUM-PHARMS-GENETIC-DISORDER.JPG",
    "domain": "thehindu.com",
    "language": "English",
    "sourcecountry": "India"
  }
}